Pathogenicity and virulence of West Nile virus revisited eight decades after its first isolation

References

• Martin-Acebes MA, Saiz JC, Saiz JC. West Nile virus: a re-emerging pathogen revisited. World J Virol. 2012;1(2):51–70.
   PubMedGoogle Scholar
• Mukhopadhyay S, Kuhn RJ, Rossmann MG. A structural perspective of the flavivirus life cycle. Nat Rev Microbiol. 2005;3(1):13–22.
   PubMed Web of Science ®Google Scholar
• Kuhn RJ, Dowd KA, Beth Post C, et al. Shake, rattle, and roll: impact of the dynamics of flavivirus particles on their interactions with the host. Virology. 2015;479-480:508–517.
   PubMed Web of Science ®Google Scholar
• Brinton MA. Replication cycle and molecular biology of the West Nile virus. Viruses. 2013;6(1):13–53.
   PubMed Web of Science ®Google Scholar
• Daffis S, Szretter KJ, Schriewer J, et al. 2ʹ-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature. 2010;468(7322):452–456.
   PubMed Web of Science ®Google Scholar
• Barrows NJ, Campos RK, Liao KC, et al. Biochemistry and Molecular Biology of Flaviviruses. Chem Rev. 2018;118(8):4448–4482.
   PubMed Web of Science ®Google Scholar
• Bidet K, Garcia-Blanco MA. Flaviviral RNA Structures and Their Role in Replication and Immunity. Adv Exp Med Biol. 2018;1062:45–62.
   PubMed Web of Science ®Google Scholar
• Schrauf S, Mandl CW, Bell-Sakyi L, et al. Extension of flavivirus protein C differentially affects early RNA synthesis and growth in mammalian and arthropod host cells. J Virol. 2009;83(21):11201–11210.
   PubMed Web of Science ®Google Scholar
• Yang MR, Lee SR, Oh W, et al. West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus. Cell Microbiol. 2008;10(1):165–176.
   PubMed Web of Science ®Google Scholar
• Medigeshi GR, Hirsch AJ, Brien JD, et al. West nile virus capsid degradation of claudin proteins disrupts epithelial barrier function. J Virol. 2009;83(12):6125–6134.
   PubMed Web of Science ®Google Scholar
• Moudy RM, Zhang B, Shi PY, et al. West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors. Virology. 2009;387(1):222–228.
   PubMed Web of Science ®Google Scholar
• Rastogi M, Sharma N, Singh SK. Flavivirus NS1: a multifaceted enigmatic viral protein. Virol J. 2016;13(1):131.
   PubMed Web of Science ®Google Scholar
• Mackenzie JM, Khromykh AA, Jones MK, et al. Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology. 1998;245(2):203–215.
   PubMed Web of Science ®Google Scholar
• Avirutnan P, Fuchs A, Hauhart RE, et al. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J Exp Med. 2010;207(4):793–806.
   PubMed Web of Science ®Google Scholar
• Melian EB, Hinzman E, Nagasaki T, et al. NS1ʹ of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. J Virol. 2010;84(3):1641–1647.
   PubMed Web of Science ®Google Scholar
• Leung JY, Pijlman GP, Kondratieva N, et al. Role of nonstructural protein NS2A in flavivirus assembly. J Virol. 2008;82(10):4731–4741.
   PubMed Web of Science ®Google Scholar
• Liu WJ, Wang XJ, Clark DC, et al. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J Virol. 2006;80(5):2396–2404.
   PubMed Web of Science ®Google Scholar
• Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, et al. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A. 2003;100(24):14333–14338.
   PubMed Web of Science ®Google Scholar
• Blazquez AB, Martin-Acebes MA, Saiz JC. Amino acid substitutions in the non-structural proteins 4A or 4B modulate the induction of autophagy in West Nile virus infected cells independently of the activation of the unfolded protein response. Front Microbiol. 2014;5:797.
   PubMed Web of Science ®Google Scholar
• Shiryaev SA, Chernov AV, Aleshin AE, et al. NS4A regulates the ATPase activity of the NS3 helicase: a novel cofactor role of the non-structural protein NS4A from West Nile virus. J Gen Virol. 2009;90(9):2081–2085.
   PubMed Web of Science ®Google Scholar
• Evans JD, Seeger C. Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling. J Virol. 2007;81(21):11809–11816.
   PubMed Web of Science ®Google Scholar
• Martin-Acebes MA, Blazquez AB, Jimenez De Oya N, et al. West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids. PLoS One. 2011;6(9):e24970.
   PubMed Web of Science ®Google Scholar
• Krishnan MN, Sukumaran B, Pal U, et al. Rab 5 is required for the cellular entry of dengue and West Nile viruses. J Virol. 2007;81(9):4881–4885.
   PubMed Web of Science ®Google Scholar
• Van Der Schaar HM, Rust MJ, Chen C, et al. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog. 2008;4(12):e1000244.
   PubMed Web of Science ®Google Scholar
• Martin-Acebes MA, Saiz JC. A West Nile virus mutant with increased resistance to acid-induced inactivation. J Gen Virol. 2011;92(4):831–840.
   PubMed Web of Science ®Google Scholar
• Gillespie LK, Hoenen A, Morgan G, et al. The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex. J Virol. 2010;84(20):10438–10447.
   PubMed Web of Science ®Google Scholar
• Mackenzie JM, Khromykh AA, Parton RG. Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe. 2007;2(4):229–239.
   PubMed Web of Science ®Google Scholar
• Fernandez-Garcia MD, Meertens L, Bonazzi M, et al. Appraising the roles of CBLL1 and the ubiquitin/proteasome system for flavivirus entry and replication. J Virol. 2011;85(6):2980–2989.
   PubMed Web of Science ®Google Scholar
• Evans JD, Crown RA, Sohn JA, et al. West Nile virus infection induces depletion of IFNAR1 protein levels. Viral Immunol. 2011;24(4):253–263.
   PubMed Web of Science ®Google Scholar
• Medigeshi GR, Lancaster AM, Hirsch AJ, et al. West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J Virol. 2007;81(20):10849–10860.
   PubMed Web of Science ®Google Scholar
• Blazquez AB, Escribano-Romero E, Merino-Ramos T, et al. Stress responses in flavivirus-infected cells: activation of unfolded protein response and autophagy. Front Microbiol. 2014;5:266.
   PubMed Web of Science ®Google Scholar
• Parquet MC, Kumatori A, Hasebe F, et al. West Nile virus-induced bax-dependent apoptosis. FEBS Lett. 2001;500(1–2):17–24.
   PubMed Web of Science ®Google Scholar
• Rizzoli A, Jimenez-Clavero MA, Barzon L, et al. The challenge of West Nile virus in Europe: knowledge gaps and research priorities. Euro Surveill. 2015;20(20). DOI:10.2807/1560-7917.ES2015.20.20.21135.
   PubMedGoogle Scholar
• May FJ, Davis CT, Tesh RB, et al. Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol. 2011;85(6):2964–2974.
   PubMed Web of Science ®Google Scholar
• Bakhshi H, Mousson L, Vazeille M, et al. High Transmission Potential of West Nile virus lineage 1 for Cx. pipiens s.l. of Iran. Viruses. 2020;12(4):397.
   PubMed Web of Science ®Google Scholar
• Charrel RN, Brault AC, Gallian P, et al. Evolutionary relationship between old world West Nile virus strains. Evidence for viral gene flow between Africa, the Middle East, and Europe. Virology. 2003;315(2):381–388.
   PubMed Web of Science ®Google Scholar
• Fall G, Diallo M, Loucoubar C, et al. Vector competence of Culex neavei and Culex quinquefasciatus (Diptera: culicidae) from Senegal for lineages 1, 2, Koutango and a putative new lineage of West Nile virus. Am J Trop Med Hyg. 2014;90(4):747–754.
   PubMed Web of Science ®Google Scholar
• Pachler K, Lebl K, Berer D, et al. Putative New West Nile Virus Lineage in Uranotaenia unguiculata Mosquitoes, Austria, 2013. Emerg Infect Dis. 2014;20(12):2119–2122.
   PubMed Web of Science ®Google Scholar
• Ciota AT. West Nile virus and its vectors. Curr Opin Insect Sci. 2017;22:28–36.
   PubMed Web of Science ®Google Scholar
• Engler O, Savini G, Papa A, et al. European surveillance for West Nile virus in mosquito populations. Int J Environ Res Public Health. 2013;10(10):4869–4895.
   PubMed Web of Science ®Google Scholar
• Fonseca DM, Smith JL, Wilkerson RC, et al. Pathways of expansion and multiple introductions illustrated by large genetic differentiation among worldwide populations of the southern house mosquito. Am J Trop Med Hyg. 2006;74(2):284–289.
   PubMed Web of Science ®Google Scholar
• Clements AN (2011) The biology of mosquitoes. Transmission of Viruses and Interactions with Bacteria.
   Google Scholar
• Gomes B, Sousa CA, Vicente JL, et al. Feeding patterns of molestus and pipiens forms of Culex pipiens (Diptera: culicidae) in a region of high hybridization. Parasit Vectors. 2013;6(1):93.
   PubMed Web of Science ®Google Scholar
• Molaei G, Andreadis TG, Armstrong PM, et al. Host feeding patterns of Culex mosquitoes and West Nile virus transmission, Northeastern United States. Emerg Infect Dis. 2006;12(3):468–474.
   PubMed Web of Science ®Google Scholar
• Saiz JC, Vazquez-Calvo A, Blazquez AB, et al. Zika Virus: the Latest Newcomer. Front Microbiol. 2016;7:496.
   PubMed Web of Science ®Google Scholar
• Birnberg L, Talavera S, Aranda C, et al. Field-captured Aedes vexans (Meigen, 1830) is a competent vector for rift valley fever phlebovirus in Europe. Parasit Vectors. 2019;12(1):484.
   PubMed Web of Science ®Google Scholar
• Khan SA, Chowdhury P, Choudhury P, et al. Detection of West Nile virus in six mosquito species in synchrony with seroconversion among sentinel chickens in India. Parasit Vectors. 2017;10(1):13.
   PubMed Web of Science ®Google Scholar
• Higgs S, Snow K, Gould EA. The potential for West Nile virus to establish outside of its natural range: a consideration of potential mosquito vectors in the United Kingdom. Trans R Soc Trop Med Hyg. 2004;98(2):82–87.
   PubMed Web of Science ®Google Scholar
• Ciota AT, Kramer LD. Vector-virus interactions and transmission dynamics of West Nile virus. Viruses. 2013;5(12):3021–3047.
   PubMed Web of Science ®Google Scholar
• Azar SR, Weaver SC. Vector competence: what has Zika virus taught us? Viruses. 2019;11(9):867.
   Web of Science ®Google Scholar
• Jerzak G, Bernard KA, Kramer LD, et al. Genetic variation in West Nile virus from naturally infected mosquitoes and birds suggests quasispecies structure and strong purifying selection. J Gen Virol. 2005;86(8):2175–2183.
   PubMed Web of Science ®Google Scholar
• Maharaj PD, Langevin SA, Bolling BG, et al. N-linked glycosylation of the West Nile virus envelope protein is not a requisite for avian virulence or vector competence. PLoS Negl Trop Dis. 2019;13(7):e0007473.
   PubMed Web of Science ®Google Scholar
• Moudy RM, Meola MA, Morin LL, et al. A newly emergent genotype of West Nile virus is transmitted earlier and more efficiently by Culex mosquitoes. Am J Trop Med Hyg. 2007;77(2):365–370.
   PubMed Web of Science ®Google Scholar
• Worwa G, Hutton AA, Frey M, et al. Increases in the competitive fitness of West Nile virus isolates after introduction into California. Virology. 2018;514:170–181.
   PubMed Web of Science ®Google Scholar
• Duggal NK, Reisen WK, Fang Y, et al. Genotype-specific variation in West Nile virus dispersal in California. Virology. 2015;485:79–85.
   PubMed Web of Science ®Google Scholar
• Brault AC, Huang CY, Langevin SA, et al. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat Genet. 2007;39(9):1162–1166.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick KA, Deardorff ER, Pesko K, et al. Population variation of West Nile virus confers a host-specific fitness benefit in mosquitoes. Virology. 2010;404(1):89–95.
   PubMed Web of Science ®Google Scholar
• Grubaugh ND, Fauver JR, Ruckert C, et al. Mosquitoes transmit unique West Nile virus populations during each feeding episode. Cell Rep. 2017;19(4):709–718.
   PubMed Web of Science ®Google Scholar
• Ciota AT, Ehrbar DJ, Van Slyke GA, et al. Quantification of intrahost bottlenecks of West Nile virus in Culex pipiens mosquitoes using an artificial mutant swarm. Infect Genet Evol. 2012;12(3):557–564.
   PubMed Web of Science ®Google Scholar
• Brackney DE, Pesko KN, Brown IK, et al. West Nile virus genetic diversity is maintained during transmission by Culex pipiens quinquefasciatus mosquitoes. PLoS One. 2011;6(9):e24466.
   PubMed Web of Science ®Google Scholar
• Grubaugh ND, Weger-Lucarelli J, Murrieta RA, et al. Genetic drift during systemic arbovirus infection of mosquito vectors leads to decreased relative fitness during host switching. Cell Host Microbe. 2016;19(4):481–492.
   PubMed Web of Science ®Google Scholar
• Brackney DE, Beane JE, Ebel GD. RNAi targeting of West Nile virus in mosquito midguts promotes virus diversification. PLoS Pathog. 2009;5(7):e1000502.
   PubMed Web of Science ®Google Scholar
• Nelms BM, Fechter-Leggett E, Carroll BD, et al. Experimental and natural vertical transmission of West Nile virus by California Culex (Diptera: culicidae) Mosquitoes. J Med Entomol. 2013;50(2):371–378.
   PubMed Web of Science ®Google Scholar
• Komar N, Langevin S, Hinten S, et al. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis. 2003;9(3):311–322.
   PubMed Web of Science ®Google Scholar
• Garmendia AE, Van Kruiningen HJ, French RA, et al. Recovery and identification of West Nile virus from a hawk in winter. J Clin Microbiol. 2000;38(8):3110–3111.
   PubMed Web of Science ®Google Scholar
• Jimenez De Oya N, Escribano-Romero E, Camacho MC, et al. A recombinant subviral particle-based vaccine protects Magpie (Pica pica) against West Nile virus infection. Front Microbiol. 2019;10:1133.
   PubMed Web of Science ®Google Scholar
• Sejvar JJ. Clinical manifestations and outcomes of West Nile virus infection. Viruses. 2014;6(2):606–623.
   PubMed Web of Science ®Google Scholar
• Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003;12(22):2196–2203.
   Web of Science ®Google Scholar
• Paisley JE, Hinckley AF, O’Leary DR, et al. West Nile virus infection among pregnant women in a northern Colorado community, 2003 to 2004. Pediatrics. 2006;117(3):814–820.
   PubMed Web of Science ®Google Scholar
• Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003;349(13):1236–1245.
   PubMed Web of Science ®Google Scholar
• Cordoba L, Escribano-Romero E, Garmendia A, et al. Pregnancy increases the risk of mortality in West Nile virus-infected mice. J Gen Virol. 2007;88(2):476–480.
   PubMed Web of Science ®Google Scholar
• Jeffrey Root J. West Nile virus associations in wild mammals: a synthesis. Arch Virol. 2013;158(4):735–752.
   PubMed Web of Science ®Google Scholar
• Bakonyi T, Ivanics E, Erdelyi K, et al. Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe. Emerg Infect Dis. 2006;12(4):618–623.
   PubMed Web of Science ®Google Scholar
• Melnick JL, Paul JR, Riordan JT, et al. Isolation from human sera in Egypt of a virus apparently identical to West Nile virus. Proc Soc Exp Biol Med. 1951;77(4):661–665.
   PubMed Web of Science ®Google Scholar
• Goldblum N, Sterk VV, Paderski B. West Nile fever; the clinical features of the disease and the isolation of West Nile virus from the blood of nine human cases. Am J Hyg. 1954;59(1):89–103.
   PubMed Web of Science ®Google Scholar
• Benjelloun A, El Harrak M, Belkadi B. West Nile Disease Epidemiology in North-West Africa: bibliographical review. Transbound Emerg Dis. 2016;63(6):e153–e159.
   PubMed Web of Science ®Google Scholar
• Ergunay K, Gunay F, Erisoz Kasap O, et al. Serological, molecular and entomological surveillance demonstrates widespread circulation of West Nile virus in Turkey. PLoS Negl Trop Dis. 2014;8(7):e3028.
   PubMed Web of Science ®Google Scholar
• Jourdain F, Samy AM, Hamidi A, et al. Towards harmonisation of entomological surveillance in the Mediterranean area. PLoS Negl Trop Dis. 2019;13(6):e0007314.
   PubMed Web of Science ®Google Scholar
• Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science. 1999;286(5448):2333–2337.
   PubMed Web of Science ®Google Scholar
• Murray KO, Mertens E, Despres P. West Nile virus and its emergence in the United States of America. Vet Res. 2010;41(6):67.
   PubMed Web of Science ®Google Scholar
• Murray KO, Walker C, Gould E. The virology, epidemiology, and clinical impact of West Nile virus: a decade of advancements in research since its introduction into the Western Hemisphere. Epidemiol Infect. 2011;139(6):807–817.
   PubMed Web of Science ®Google Scholar
• Komar N, Clark GG. West Nile virus activity in Latin America and the Caribbean. Rev Panam Salud Publica. 2006;19(2):112–117.
   PubMed Web of Science ®Google Scholar
• Kramer LD, Ciota AT, Kilpatrick AM. Introduction, Spread, and Establishment of West Nile virus in the Americas. J Med Entomol. 2019;56(6):1448–1455.
   PubMed Web of Science ®Google Scholar
• Elizondo-Quiroga D, Elizondo-Quiroga A. West nile virus and its theories, a big puzzle in Mexico and latin america. J Glob Infect Dis. 2013;5(4):168–175.
   PubMedGoogle Scholar
• Beasley DW, Davis CT, Estrada-Franco J, et al. Genome sequence and attenuating mutations in West Nile virus isolate from Mexico. Emerg Infect Dis. 2004;10(12):2221–2224.
   PubMed Web of Science ®Google Scholar
• Smithburn KC, Hughes TP, Burke AW, et al. A neurotropic virus isolated from the blood of a native of Uganda 1. Am J Trop Med Hyg. 1940;s1-20(4):471–492.
   Google Scholar
• Sule WF, Oluwayelu DO, Hernandez-Triana LM, et al. Epidemiology and ecology of West Nile virus in sub-Saharan Africa. Parasit Vectors. 2018;11(1):414.
   PubMed Web of Science ®Google Scholar
• Jupp PG. The ecology of West Nile virus in South Africa and the occurrence of outbreaks in humans. Ann N Y Acad Sci. 2001;951(1):143–152.
   PubMed Web of Science ®Google Scholar
• Atkinson B, Hewson R. Emerging arboviruses of clinical importance in Central Asia. J Gen Virol. 2018;99(9):1172–1184.
   PubMed Web of Science ®Google Scholar
• Platonov AE, Shipulin GA, Shipulina OY, et al. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis. 2001;7(1):128–132.
   PubMed Web of Science ®Google Scholar
• David S, Abraham AM. Epidemiological and clinical aspects on West Nile virus, a globally emerging pathogen. Infect Dis (Lond). 2016;48(8):571–586.
   PubMed Web of Science ®Google Scholar
• Anukumar B, Sapkal GN, Tandale BV, et al. West Nile encephalitis outbreak in Kerala, India, 2011. J Clin Virol. 2014;61(1):152–155.
   PubMed Web of Science ®Google Scholar
• Tandel K, Sharma S, Dash PK, et al. Emergence of human West Nile virus infection among pediatric population in Madhya Pradesh, India. J Med Virol. 2019;91(3):493–497.
   PubMed Web of Science ®Google Scholar
• Mackenzie JS, Williams DT. The zoonotic flaviviruses of southern, south-eastern and eastern Asia, and Australasia: the potential for emergent viruses. Zoonoses Public Health. 2009;56(6–7):338–356.
   PubMed Web of Science ®Google Scholar
• Lan DL, Wang CS, Deng B, et al. Serological investigations on West Nile virus in birds and horses in Shanghai, China. Epidemiol Infect. 2013;141(3):596–600.
   PubMed Web of Science ®Google Scholar
• Lu Z, Fu SH, Cao L, et al. Human infection with West Nile virus, Xinjiang, China, 2011. Emerg Infect Dis. 2014;20(8):1421–1423.
   PubMed Web of Science ®Google Scholar
• Russell RC, Dwyer DE. Arboviruses associated with human disease in Australia. Microbes Infect. 2000;2(14):1693–1704.
   PubMed Web of Science ®Google Scholar
• Frost MJ, Zhang J, Edmonds JH, et al. Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. Emerg Infect Dis. 2012;18(5):792–800.
   PubMed Web of Science ®Google Scholar
• Read AJ, Finlaison DS, Gu X, et al. Clinical and epidemiological features of West Nile virus equine encephalitis in New South Wales, Australia, 2011. Aust Vet J. 2019;97(5):133–143.
   PubMed Web of Science ®Google Scholar
• Schneider BS, Soong L, Coffey LL, et al. Aedes aegypti saliva alters leukocyte recruitment and cytokine signaling by antigen-presenting cells during West Nile virus infection. PLoS One. 2010;5(7):e11704.
   PubMed Web of Science ®Google Scholar
• Diamond MS, Gale M Jr. Cell-intrinsic innate immune control of West Nile virus infection. Trends Immunol. 2012;33(10):522–530.
   PubMed Web of Science ®Google Scholar
• Bai F, Kong KF, Dai J, et al. A paradoxical role for neutrophils in the pathogenesis of West Nile virus. J Infect Dis. 2010;202(12):1804–1812.
   PubMed Web of Science ®Google Scholar
• Demeure CE, Brahimi K, Hacini F, et al. Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J Immunol. 2005;174(7):3932–3940.
   PubMed Web of Science ®Google Scholar
• Ribeiro JM, Charlab R, Valenzuela JG. The salivary adenosine deaminase activity of the mosquitoes Culex quinquefasciatus and Aedes aegypti. J Exp Biol. 2001;204(Pt 11):2001–2010.
   PubMed Web of Science ®Google Scholar
• Schneider BS, McGee CE, Jordan JM, et al. Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West Nile virus infection. PLoS One. 2007;2:e1171.
   PubMed Web of Science ®Google Scholar
• Pingen M, Schmid MA, Harris E, et al. Mosquito biting modulates skin response to virus infection. Trends Parasitol. 2017;33(8):645–657.
   PubMed Web of Science ®Google Scholar
• Garcia M, Alout H, Diop F, et al. Innate immune response of primary human keratinocytes to West Nile virus infection and its modulation by mosquito saliva. Front Cell Infect Microbiol. 2018;8:387.
   PubMed Web of Science ®Google Scholar
• Hoover LI, Fredericksen BL. IFN-dependent and -independent reduction in West Nile virus infectivity in human dermal fibroblasts. Viruses. 2014;6(3):1424–1441.
   PubMed Web of Science ®Google Scholar
• Perera-Lecoin M, Meertens L, Carnec X, et al. Flavivirus entry receptors: an update. Viruses. 2013;6(1):69–88.
   PubMed Web of Science ®Google Scholar
• Mercer J. Viral apoptotic mimicry party: p.S. Bring your own Gas6. Cell Host Microbe. 2011;9(4):255–257.
   PubMed Web of Science ®Google Scholar
• Fruscoloni P, Zamboni M, Baldi MI, et al. Exonucleolytic degradation of double-stranded RNA by an activity in Xenopus laevis germinal vesicles. Proc Natl Acad Sci U S A. 2003;100(4):1639–1644.
   PubMed Web of Science ®Google Scholar
• Meertens L, Carnec X, Lecoin MP, et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe. 2012;12(4):544–557.
   PubMed Web of Science ®Google Scholar
• Miner JJ, Daniels BP, Shrestha B, et al. The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. Nat Med. 2015;21(12):1464–1472.
   PubMed Web of Science ®Google Scholar
• Schmid ET, Pang IK, Carrera Silva EA, et al. AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity. Elife. 2016;5. DOI:10.7554/eLife.12414.
   Web of Science ®Google Scholar
• Qian F, Wang X, Zhang L, et al. Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis. 2011;203(10):1415–1424.
   PubMed Web of Science ®Google Scholar
• Best SM. Viruses PLAY DEAD to TAMe interferon responses. Cell Host Microbe. 2013;14(2):117–118.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Zagorska A, Lew ED, et al. Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors. Cell Host Microbe. 2013;14(2):136–147.
   PubMed Web of Science ®Google Scholar
• Samuel MA, Diamond MS. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol. 2005;79(21):13350–13361.
   PubMed Web of Science ®Google Scholar
• Shrestha B, Wang T, Samuel MA, et al. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol. 2006;80(11):5338–5348.
   PubMed Web of Science ®Google Scholar
• Suthar MS, Ma DY, Thomas S, et al. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 2010;6(2):e1000757.
   PubMed Web of Science ®Google Scholar
• Szretter KJ, Daffis S, Patel J, et al. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J Virol. 2010;84(23):12125–12138.
   PubMed Web of Science ®Google Scholar
• Daffis S, Samuel MA, Suthar MS, et al. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol. 2008;82(17):8465–8475.
   PubMed Web of Science ®Google Scholar
• Errett JS, Suthar MS, McMillan A, et al. The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection. J Virol. 2013;87(21):11416–11425.
   PubMed Web of Science ®Google Scholar
• Wang T, Town T, Alexopoulou L, et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med. 2004;10(12):1366–1373.
   PubMed Web of Science ®Google Scholar
• Daffis S, Samuel MA, Suthar MS, et al. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol. 2008;82(21):10349–10358.
   PubMed Web of Science ®Google Scholar
• Gack MU, Diamond MS. Innate immune escape by dengue and West Nile viruses. Curr Opin Virol. 2016;20:119–128.
   PubMed Web of Science ®Google Scholar
• Arjona A, Ledizet M, Anthony K, et al. West Nile virus envelope protein inhibits dsRNA-induced innate immune responses. J Immunol. 2007;179(12):8403–8409.
   PubMed Web of Science ®Google Scholar
• Liu WJ, Wang XJ, Mokhonov VV, et al. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol. 2005;79(3):1934–1942.
   PubMed Web of Science ®Google Scholar
• Zhang HL, Ye HQ, Liu SQ, et al. West Nile Virus NS1 antagonizes interferon beta production by targeting RIG-I and MDA5. J Virol. 2017;91(18). DOI:10.1128/JVI.02396-16.
   Web of Science ®Google Scholar
• Hershkovitz O, Rosental B, Rosenberg LA, et al. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol. 2009;183(4):2610–2621.
   PubMed Web of Science ®Google Scholar
• Zhang M, Daniel S, Huang Y, et al. Anti-West Nile virus activity of in vitro expanded human primary natural killer cells. BMC Immunol. 2010;11(1):3.
   PubMed Web of Science ®Google Scholar
• Yao Y, Strauss-Albee DM, Zhou JQ, et al. The natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infection. PLoS One. 2017;12(2):e0172625.
   PubMed Web of Science ®Google Scholar
• Shrestha B, Samuel MA, Diamond MS. CD8+ T cells require perforin to clear West Nile virus from infected neurons. J Virol. 2006;80(1):119–129.
   PubMed Web of Science ®Google Scholar
• Wang T, Scully E, Yin Z, et al. IFN-γ-producing γδ T cells help control murine West Nile virus infection. J Immunol. 2003;171(5):2524–2531.
   PubMed Web of Science ®Google Scholar
• Welte T, Lamb J, Anderson JF, et al. Role of two distinct gammadelta T cell subsets during West Nile virus infection. FEMS Immunol Med Microbiol. 2008;53(2):275–283.
   PubMedGoogle Scholar
• Fang H, Welte T, Zheng X, et al. Gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection. FEMS Immunol Med Microbiol. 2010;59(1):71–80.
   PubMedGoogle Scholar
• Wang T, Gao Y, Scully E, et al. Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice. J Immunol. 2006;177(3):1825–1832.
   PubMed Web of Science ®Google Scholar
• Mak TW, Saunders ME, Jett BD. NK, γδ T and NKT Cells. In: Mak TW, Saunders ME, JetBD, editors. Primer to the immune response (Second Edition). 2014. p. 247–268
   Google Scholar
• Kovats S, Turner S, Simmons A, et al. West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells. Clin Exp Immunol. 2016;186(2):214–226.
   PubMed Web of Science ®Google Scholar
• Rios M, Zhang MJ, Grinev A, et al. Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion. Transfusion. 2006;46(4):659–667.
   PubMed Web of Science ®Google Scholar
• Lim JK, Obara CJ, Rivollier A, et al. Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis. J Immunol. 2011;186(1):471–478.
   PubMed Web of Science ®Google Scholar
• Getts DR, Terry RL, Getts MT, et al. Ly6c+ “inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med. 2008;205(10):2319–2337.
   PubMed Web of Science ®Google Scholar
• Peiris JS, Porterfield JS. Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines. Nature. 1979;282(5738):509–511.
   PubMed Web of Science ®Google Scholar
• Martin-Acebes MA, Saiz JC, Jimenez De Oya N. Antibody-dependent enhancement and Zika: real threat or Phantom Menace? Front Cell Infect Microbiol. 2018;8:44.
   PubMed Web of Science ®Google Scholar
• Kong KF, Wang X, Anderson JF, et al. West nile virus attenuates activation of primary human macrophages. Viral Immunol. 2008;21(1):78–82.
   PubMed Web of Science ®Google Scholar
• Ben-Nathan D, Huitinga I, Lustig S, et al. West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice. Arch Virol. 1996;141(3–4):459–469.
   PubMed Web of Science ®Google Scholar
• Bryan MA, Giordano D, Draves KE, et al. Splenic macrophages are required for protective innate immunity against West Nile virus. PLoS One. 2018;13(2):e0191690.
   PubMed Web of Science ®Google Scholar
• Kong KF, Delroux K, Wang X, et al. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol. 2008;82(15):7613–7623.
   PubMed Web of Science ®Google Scholar
• Bai F, Thompson EA, Vig PJS, et al. Current understanding of West Nile virus clinical manifestations, immune responses, neuroinvasion, and immunotherapeutic implications. Pathogens. 2019;8(4):193.
   Web of Science ®Google Scholar
• Silva MC, Guerrero-Plata A, Gilfoy FD, et al. Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells. J Virol. 2007;81(24):13640–13648.
   PubMed Web of Science ®Google Scholar
• Zimmerman MG, Bowen JR, McDonald CE, et al. West Nile virus infection blocks inflammatory response and T cell costimulatory capacity of human monocyte-derived dendritic cells. J Virol. 2019;93(23). DOI:10.1128/JVI.00664-19.
   Web of Science ®Google Scholar
• Pinto AK, Ramos HJ, Wu X, et al. Deficient IFN signaling by myeloid cells leads to MAVS-dependent virus-induced sepsis. PLoS Pathog. 2014;10(4):e1004086.
   PubMed Web of Science ®Google Scholar
• Diamond MS, Shrestha B, Marri A, et al. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol. 2003;77(4):2578–2586.
   PubMed Web of Science ®Google Scholar
• Mehlhop E, Whitby K, Oliphant T, et al. Complement activation is required for induction of a protective antibody response against West Nile virus infection. J Virol. 2005;79(12):7466–7477.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lobigs M, Lee E, et al. CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol. 2003;77(24):13323–13334.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lobigs M, Lee E, et al. CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon. J Gen Virol. 2006;87(12):3599–3609.
   PubMed Web of Science ®Google Scholar
• Sitati EM, Diamond MS. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J Virol. 2006;80(24):12060–12069.
   PubMed Web of Science ®Google Scholar
• Brien JD, Uhrlaub JL, Nikolich-Zugich J. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J Immunol. 2008;181(12):8568–8575.
   PubMed Web of Science ®Google Scholar
• Shrestha B, Diamond MS. Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system. J Virol. 2007;81(21):11749–11757.
   PubMed Web of Science ®Google Scholar
• Acharya D, Wang P, Paul AM, et al. Interleukin-17A Promotes CD8+ T cell cytotoxicity to facilitate West Nile virus clearance. J Virol. 2017;91(1). DOI:10.1128/JVI.01529-16.
   Web of Science ®Google Scholar
• Shrestha B, Pinto AK, Green S, et al. CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons. J Virol. 2012;86(17):8937–8948.
   PubMed Web of Science ®Google Scholar
• Sitati E, McCandless EE, Klein RS, et al. CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis. J Virol. 2007;81(18):9801–9811.
   PubMed Web of Science ®Google Scholar
• Klein RS, Lin E, Zhang B, et al. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol. 2005;79(17):11457–11466.
   PubMed Web of Science ®Google Scholar
• Glass WG, Lim JK, Cholera R, et al. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med. 2005;202(8):1087–1098.
   PubMed Web of Science ®Google Scholar
• Bardina SV, Brown JA, Michlmayr D, et al. Chemokine receptor Ccr7 restricts fatal West Nile virus encephalitis. J Virol. 2017;91(10). DOI:10.1128/JVI.02409-16.
   PubMed Web of Science ®Google Scholar
• Wang S, Welte T, McGargill M, et al. Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis. J Immunol. 2008;181(3):2084–2091.
   PubMed Web of Science ®Google Scholar
• Richner JM, Gmyrek GB, Govero J, et al. Age-dependent cell trafficking defects in draining lymph nodes impair adaptive immunity and control of West Nile virus infection. PLoS Pathog. 2015;11(7):e1005027.
   PubMed Web of Science ®Google Scholar
• Brien JD, Uhrlaub JL, Hirsch A, et al. Key role of T cell defects in age-related vulnerability to West Nile virus. J Exp Med. 2009;206(12):2735–2745.
   PubMed Web of Science ®Google Scholar
• James EA, Gates TJ, LaFond RE, et al. Neuroinvasive West Nile infection elicits elevated and atypically Polarized T cell responses that promote a pathogenic outcome. PLoS Pathog. 2016;12(1):e1005375.
   PubMed Web of Science ®Google Scholar
• Lanteri MC, O’Brien KM, Purtha WE, et al. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest. 2009;119(11):3266–3277.
   PubMed Web of Science ®Google Scholar
• Sejvar JJ. West Nile virus infection. Microbiol Spectr. 2016;4(3). DOI:10.1128/microbiolspec.EI10-0021-2016
   PubMed Web of Science ®Google Scholar
• Campbell GL, Marfin AA, Lanciotti RS, et al. West Nile virus. Lancet Infect Dis. 2002;2(9):519–529.
   PubMed Web of Science ®Google Scholar
• Byas AD, Ebel GD. Comparative pathology of West Nile virus in humans and non-human animals. Pathogens. 2020;9(1):48.
   PubMed Web of Science ®Google Scholar
• Yeung MW, Shing E, Nelder M, et al. Epidemiologic and clinical parameters of West Nile virus infections in humans: a scoping review. BMC Infect Dis. 2017;17(1):609.
   PubMed Web of Science ®Google Scholar
• Hayes EB, Sejvar JJ, Zaki SR, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11(8):1174–1179.
   PubMed Web of Science ®Google Scholar
• Murray KO, Nolan MS, Ronca SE, et al. The neurocognitive and MRI outcomes of West Nile virus infection: preliminary analysis using an external control group. Front Neurol. 2018;9:111.
   PubMed Web of Science ®Google Scholar
• Bakri SJ, Kaiser PK. Ocular manifestations of West Nile virus. Curr Opin Ophthalmol. 2004;15(6):537–540.
   PubMedGoogle Scholar
• Bains HS, Jampol LM, Caughron MC, et al. Vitritis and chorioretinitis in a patient with West Nile virus infection. Arch Ophthalmol. 2003;121:205–207.
   PubMedGoogle Scholar
• Armah HB, Wang G, Omalu BI, et al. Systemic distribution of West Nile virus infection: postmortem immunohistochemical study of six cases. Brain Pathol. 2007;17(4):354–362.
   PubMed Web of Science ®Google Scholar
• Paddock CD, Nicholson WL, Bhatnagar J, et al. Fatal hemorrhagic fever caused by West Nile virus in the United States. Clin Infect Dis. 2006;42(11):1527–1535.
   PubMed Web of Science ®Google Scholar
• Angenvoort J, Brault AC, Bowen RA, et al. West Nile viral infection of equids. Vet Microbiol. 2013;167:168–180.
   PubMed Web of Science ®Google Scholar
• Gamino V, Hofle U. Pathology and tissue tropism of natural West Nile virus infection in birds: a review. Vet Res. 2013;44(1):39.
   PubMed Web of Science ®Google Scholar
• Jimenez De Oya N, Escribano-Romero E, Blazquez AB, et al. Current progress of avian vaccines against West Nile virus. Vaccines (Basel). 2019;7(4). DOI:10.3390/vaccines7040126.
   PubMed Web of Science ®Google Scholar
• Jimenez De Oya N, Camacho MC, Blazquez AB, et al. High susceptibility of magpie (Pica pica) to experimental infection with lineage 1 and 2 West Nile virus. PLoS Negl Trop Dis. 2018;12(4):e0006394.
   PubMed Web of Science ®Google Scholar
• Gamino V, Escribano-Romero E, Gutierrez-Guzman AV, et al. Oculopathologic findings in flavivirus-infected gallinaceous birds. Vet Pathol. 2014;51(6):1113–1116.
   PubMed Web of Science ®Google Scholar
• Garcia MN, Hasbun R, Murray KO. Persistence of West Nile virus. Microbes Infect. 2015;17(2):163–168.
   PubMed Web of Science ®Google Scholar
• Murray K, Walker C, Herrington E, et al. Persistent infection with West Nile virus years after initial infection. J Infect Dis. 2010;201(1):2–4.
   PubMed Web of Science ®Google Scholar
• Penn RG, Guarner J, Sejvar JJ, et al. Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. Clin Infect Dis. 2006;42(5):680–683.
   PubMed Web of Science ®Google Scholar
• Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases. Emerg Infect Dis. 2003;9(3):376–379.
   PubMed Web of Science ®Google Scholar
• Diniz JA, Da Rosa AP, Guzman H, et al. West Nile virus infection of primary mouse neuronal and neuroglial cells: the role of astrocytes in chronic infection. Am J Trop Med Hyg. 2006;75(4):691–696.
   PubMed Web of Science ®Google Scholar
• Potokar M, Jorgacevski J, Zorec R. Astrocytes in flavivirus infections. Int J Mol Sci. 2019;20(3):691.
   PubMed Web of Science ®Google Scholar
• Pogodina VV, Frolova MP, Malenko GV, et al. Study on West Nile virus persistence in monkeys. Arch Virol. 1983;75(1–2):71–86.
   PubMed Web of Science ®Google Scholar
• Xiao SY, Guzman H, Zhang H, et al. West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg Infect Dis. 2001;7(4):714–721.
   PubMed Web of Science ®Google Scholar
• Appler KK, Brown AN, Stewart BS, et al. Persistence of West Nile virus in the central nervous system and periphery of mice. PLoS One. 2010;5(5):e10649.
   PubMed Web of Science ®Google Scholar
• Saxena V, Xie G, Li B, et al. A hamster-derived West Nile virus isolate induces persistent renal infection in mice. PLoS Negl Trop Dis. 2013;7(6):e2275.
   PubMed Web of Science ®Google Scholar
• Wheeler SS, Langevin SA, Brault AC, et al. Detection of persistent west nile virus RNA in experimentally and naturally infected avian hosts. Am J Trop Med Hyg. 2012;87(3):559–564.
   PubMed Web of Science ®Google Scholar
• Samuel MA, Diamond MS. Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol. 2006;80(19):9349–9360.
   PubMed Web of Science ®Google Scholar
• Shrestha B, Gottlieb D, Diamond MS. Infection and injury of neurons by West Nile encephalitis virus. J Virol. 2003;77(24):13203–13213.
   PubMed Web of Science ®Google Scholar
• Peng BH, Wang T. West Nile virus induced cell death in the central nervous system. Pathogens. 2019;8(4):215.
   Web of Science ®Google Scholar
• Clarke P, Leser JS, Quick ED, et al. Death receptor-mediated apoptotic signaling is activated in the brain following infection with West Nile virus in the absence of a peripheral immune response. J Virol. 2014;88(2):1080–1089.
   PubMed Web of Science ®Google Scholar
• Lesteberg KE, Beckham JD. Immunology of West Nile virus infection and the role of Alpha-Synuclein as a viral restriction factor. Viral Immunol. 2019;32(1):38–47.
   PubMed Web of Science ®Google Scholar
• Beatman E, Oyer R, Shives KD, et al. West Nile virus growth is independent of autophagy activation. Virology. 2012;433(1):262–272.
   PubMed Web of Science ®Google Scholar
• Vandergaast R, Fredericksen BL. West Nile virus (WNV) replication is independent of autophagy in mammalian cells. PLoS One. 2012;7(9):e45800.
   PubMed Web of Science ®Google Scholar
• Martin-Acebes MA, Blazquez AB, Saiz JC. Reconciling West Nile virus with the autophagic pathway. Autophagy. 2015;11(5):861–864.
   PubMed Web of Science ®Google Scholar
• Shi PY, Wong SJ. Serologic diagnosis of West Nile virus infection. Expert Rev Mol Diagn. 2003;3(6):733–741.
   PubMed Web of Science ®Google Scholar
• Dauphin G, Zientara S. West Nile virus: recent trends in diagnosis and vaccine development. Vaccine. 2007;25(30):5563–5576.
   PubMed Web of Science ®Google Scholar
• Shi PY, Kauffman EB, Ren P, et al. High-throughput detection of West Nile virus RNA. J Clin Microbiol. 2001;39(4):1264–1271.
   PubMed Web of Science ®Google Scholar
• Wilson MR, Zimmermann LL, Crawford ED, et al. Acute West Nile virus meningoencephalitis diagnosed via metagenomic deep sequencing of cerebrospinal fluid in a renal transplant patient. Am J Transplant. 2017;17(3):803–808.
   PubMed Web of Science ®Google Scholar
• Sinigaglia A, Peta E, Riccetti S, et al. New avenues for therapeutic discovery against West Nile virus. Expert Opin Drug Discov. 2020;15(3):333–348.
   PubMed Web of Science ®Google Scholar
• Krishnan MN, Garcia-Blanco MA. Targeting host factors to treat West Nile and dengue viral infections. Viruses. 2014;6(2):683–708.
   PubMed Web of Science ®Google Scholar
• De Wispelaere M, Lian W, Potisopon S, et al. Inhibition of flaviviruses by targeting a conserved pocket on the viral envelope protein. Cell Chem Biol. 2018;25(8):1006–1016 e1008.
   PubMed Web of Science ®Google Scholar
• Haviernik J, Stefanik M, Fojtikova M, et al. Arbidol (Umifenovir): a broad-spectrum antiviral drug that inhibits medically important arthropod-borne flaviviruses. Viruses. 2018;10(4):184.
   PubMed Web of Science ®Google Scholar
• Vazquez-Calvo A, Jimenez De Oya N, Martin-Acebes MA, et al. Antiviral properties of the natural polyphenols delphinidin and epigallocatechin gallate against the flaviviruses West Nile virus, Zika virus, and Dengue virus. Front Microbiol. 2017;8:1314.
   PubMed Web of Science ®Google Scholar
• Pliego Zamora A, Edmonds JH, Reynolds MJ, et al. The in vitro and in vivo antiviral properties of combined monoterpene alcohols against West Nile virus infection. Virology. 2016;495:18–32.
   PubMed Web of Science ®Google Scholar
• Prochnow H, Rox K, Birudukota NVS, et al. Labyrinthopeptins exert broad-spectrum antiviral activity through lipid-binding-mediated virolysis. J Virol. 2020;94(2). DOI:10.1128/JVI.01471-19.
   PubMed Web of Science ®Google Scholar
• Nitsche C. Strategies towards protease inhibitors for emerging flaviviruses. Adv Exp Med Biol. 2018;1062:175–186.
   PubMed Web of Science ®Google Scholar
• Mastrangelo E, Pezzullo M, De Burghgraeve T, et al. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J Antimicrob Chemother. 2012;67(8):1884–1894.
   PubMed Web of Science ®Google Scholar
• Yang SNY, Atkinson SC, Wang C, et al. The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha/beta1 heterodimer. Antiviral Res. 2020;177:104760.
   PubMed Web of Science ®Google Scholar
• Bullard KM, Gullberg RC, Soltani E, et al. Murine efficacy and Pharmacokinetic evaluation of the Flaviviral NS5 capping Enzyme 2-Thioxothiazolidin-4-one inhibitor BG-323. PLoS One. 2015;10(6):e0130083.
   PubMed Web of Science ®Google Scholar
• Anderson JF, Rahal JJ. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis. 2002;8(1):107–108.
   PubMed Web of Science ®Google Scholar
• Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis. 2008;47(3):303–327.
   PubMed Web of Science ®Google Scholar
• Eyer L, Fojtikova M, Nencka R, et al. Viral RNA-dependent RNA polymerase inhibitor 7-Deaza-2′-C-Methyladenosine prevents death in a mouse model of West Nile virus infection. Antimicrob Agents Chemother. 2019;63(3). DOI:10.1128/AAC.02093-18.
   PubMed Web of Science ®Google Scholar
• Nelson J, Roe K, Orillo B, et al. Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection. Antiviral Res. 2015;122:39–45.
   PubMed Web of Science ®Google Scholar
• Eyer L, Nencka R, De Clercq E, et al. Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses. Antivir Chem Chemother. 2018;26:2040206618761299.
   Google Scholar
• Eyer L, Zouharova D, Sirmarova J, et al. Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses. Antiviral Res. 2017;142:63–67.
   PubMed Web of Science ®Google Scholar
• Morrey JD, Taro BS, Siddharthan V, et al. Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents. Antiviral Res. 2008;80(3):377–379.
   PubMed Web of Science ®Google Scholar
• Furuta Y, Komeno T, Nakamura T. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(7):449–463.
   PubMed Web of Science ®Google Scholar
• Escribano-Romero E, Jimenez De Oya N, Domingo E, et al. Extinction of West Nile virus by Favipiravir through lethal mutagenesis. Antimicrob Agents Chemother. 2017;61(11). DOI:10.1128/AAC.01400-17.
   PubMed Web of Science ®Google Scholar
• Dragoni F, Boccuto A, Picarazzi F, et al. Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro. Antiviral Res. 2020;175:104708.
   PubMed Web of Science ®Google Scholar
• Deas TS, Binduga-Gajewska I, Tilgner M, et al. Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. J Virol. 2005;79(8):4599–4609.
   PubMed Web of Science ®Google Scholar
• Diamond MS. Progress on the development of therapeutics against West Nile virus. Antiviral Res. 2009;83(3):214–227.
   PubMed Web of Science ®Google Scholar
• Puschnik AS, Marceau CD, Ooi YS, et al. A small-molecule Oligosaccharyltransferase inhibitor with pan-flaviviral activity. Cell Rep. 2017;21(11):3032–3039.
   PubMed Web of Science ®Google Scholar
• Ivanova T, Hardes K, Kallis S, et al. Optimization of Substrate-Analogue Furin Inhibitors. ChemMedChem. 2017;12(23):1953–1968.
   PubMed Web of Science ®Google Scholar
• Brai A, Fazi R, Tintori C, et al. Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents. Proc Natl Acad Sci U S A. 2016;113(19):5388–5393.
   PubMed Web of Science ®Google Scholar
• Blazquez AB, Vazquez-Calvo A, Martin-Acebes MA, et al. Pharmacological inhibition of protein Kinase C reduces West Nile virus replication. Viruses. 2018;10(2): 91.
   Web of Science ®Google Scholar
• Jimenez De Oya N, Blazquez AB, Casas J, et al. Direct activation of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by PF-06409577 inhibits Flavivirus infection through modification of host cell lipid metabolism. Antimicrob Agents Chemother. 2018;62(7). DOI:10.1128/AAC.00360-18.
   PubMed Web of Science ®Google Scholar
• Martin-Acebes MA, Vazquez-Calvo A, Saiz JC. Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses. Prog Lipid Res. 2016;64:123–137.
   PubMed Web of Science ®Google Scholar
• Jimenez De Oya N, Esler WP, Huard K, et al. Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models. Emerg Microbes Infect. 2019;8(1):624–636.
   PubMed Web of Science ®Google Scholar
• Blazquez AB, Martin-Acebes MA, Saiz JC. Inhibition of West Nile virus multiplication in cell culture by anti-parkinsonian drugs. Front Microbiol. 2016;7:296.
   PubMed Web of Science ®Google Scholar
• Vazquez-Calvo A, Saiz JC, Sobrino F, et al. Inhibition of enveloped virus infection of cultured cells by valproic acid. J Virol. 2011;85(3):1267–1274.
   PubMed Web of Science ®Google Scholar
• Morrey JD, Day CW, Julander JG, et al. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antivir Chem Chemother. 2004;15(2):101–109.
   PubMedGoogle Scholar
• Rodriguez-Pulido M, Martin-Acebes MA, Escribano-Romero E, et al. Protection against West Nile virus infection in mice after inoculation with type I interferon-inducing RNA transcripts. PLoS One. 2012;7(11):e49494.
   PubMed Web of Science ®Google Scholar
• Quirk M. First treatment trial for West Nile infection begins. Lancet Infect Dis. 2002;2(10):589.
   PubMed Web of Science ®Google Scholar
• Daffis S, Suthar MS, Gale M Jr., et al. Measure and countermeasure: type I IFN (IFN-α/β) antiviral response against West Nile virus. J Innate Immun. 2009;1(5):435–445.
   PubMed Web of Science ®Google Scholar
• Chan-Tack KM, Forrest G. Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid paralysis. Scand J Infect Dis. 2005;37(11–12):944–946.
   PubMed Web of Science ®Google Scholar
• Ben-Nathan D, Lustig S, Tam G, et al. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis. 2003;188(1):5–12.
   PubMed Web of Science ®Google Scholar
• Morrey JD, Siddharthan V, Olsen AL, et al. Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters. J Infect Dis. 2006;194(9):1300–1308.
   PubMed Web of Science ®Google Scholar
• Shimoni Z, Bin H, Bulvik S, et al. The clinical response of West Nile virus neuroinvasive disease to intravenous immunoglobulin therapy. Clin Pract. 2012;2(1):e18.
   PubMedGoogle Scholar
• Hart J Jr., Tillman G, Kraut MA, et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis. 2014;14(1):248.
   PubMed Web of Science ®Google Scholar
• Nybakken GE, Oliphant T, Johnson S, et al. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature. 2005;437(7059):764–769.
   PubMed Web of Science ®Google Scholar
• Oliphant T, Engle M, Nybakken GE, et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med. 2005;11(5):522–530.
   PubMed Web of Science ®Google Scholar
• Beigel JH, Nordstrom JL, Pillemer SR, et al. Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus. Antimicrob Agents Chemother. 2010;54(6):2431–2436.
   PubMed Web of Science ®Google Scholar
• Kaiser JA, Barrett ADT. Twenty years of progress toward West Nile virus vaccine development. Viruses. 2019;11(9):823.
   Web of Science ®Google Scholar
• Gould LH, Fikrig E. West Nile virus: a growing concern? J Clin Invest. 2004;113(8):1102–1107.
   PubMed Web of Science ®Google Scholar
• Petersen LR, Roehrig JT. Flavivirus DNA vaccines–good science, uncertain future. J Infect Dis. 2007;196(12):1721–1723.
   PubMed Web of Science ®Google Scholar
• Gardner IA, Wong SJ, Ferraro GL, et al. Incidence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California. Vet Res. 2007;38(1):109–116.
   PubMed Web of Science ®Google Scholar
• Chaintoutis SC, Diakakis N, Papanastassopoulou M, et al. Evaluation of cross-protection of a Lineage 1 West Nile virus inactivated vaccine against natural infections from a virulent Lineage 2 strain in horses, under field conditions. Clin Vaccine Immunol. 2015;22(9):1040–1049.
   PubMedGoogle Scholar
• Minke JM, Siger L, Cupillard L, et al. Protection provided by a recombinant ALVAC((R))-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain. Vaccine. 2011;29(28):4608–4612.
   PubMed Web of Science ®Google Scholar
• Venter M, Van Vuren PJ, Mentoor J, et al. Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice. Vaccine. 2013;31(37):3856–3862.
   PubMed Web of Science ®Google Scholar
• Merino-Ramos T, Blazquez AB, Escribano-Romero E, et al. Protection of a single dose west nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus. PLoS One. 2014;9(9):e108056.
   PubMed Web of Science ®Google Scholar
• Bardina SV, Bunduc P, Tripathi S, et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science. 2017;356(6334):175–180.
   PubMed Web of Science ®Google Scholar
• Pierson TC, Xu Q, Nelson S, et al. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe. 2007;1(2):135–145.
   PubMed Web of Science ®Google Scholar
• Lobigs M, Diamond MS. Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex. Expert Rev Vaccines. 2012;11(2):177–187.
   PubMed Web of Science ®Google Scholar
• Vazquez-Calvo A, Blazquez AB, Escribano-Romero E, et al. Zika virus infection confers protection against West Nile virus challenge in mice. Emerg Microbes Infect. 2017;6(9):e81.
   PubMed Web of Science ®Google Scholar
• Suthar MS, Diamond MS, Gale M Jr. West Nile virus infection and immunity. Nat Rev Microbiol. 2013;11(2):115–128.
   PubMed Web of Science ®Google Scholar
• Olberg RA, Barker IK, Crawshaw GJ, et al. West Nile virus encephalitis in a Barbary Macaque (Macaca sylvanus). Emerg Infect Dis. 2004;10(4):712–714.
   PubMed Web of Science ®Google Scholar
• Blackburn NK, Reyers F, Berry WL, et al. Susceptibility of dogs to West Nile virus: a survey and pathogenicity trial. J Comp Pathol. 1989;100(1):59–66.
   PubMed Web of Science ®Google Scholar
• Lichtensteiger CA, Heinz-Taheny K, Osborne TS, et al. West Nile virus encephalitis and myocarditis in wolf and dog. Emerg Infect Dis. 2003;9(10):1303–1306.
   PubMed Web of Science ®Google Scholar
• Habarugira G, Moran J, Colmant AMG, et al. Mosquito-independent transmission of West Nile virus in farmed saltwater crocodiles (Crocodylus porosus). Viruses. 2020;12(2):198.
   PubMed Web of Science ®Google Scholar
• Del Piero F, Stremme DW, Habecker PL, et al. West Nile Flavivirus Polioencephalomyelitis in a harbor seal (Phoca vitulina). Vet Pathol. 2006;43(1):58–61.
   PubMed Web of Science ®Google Scholar
• Palmer MV, Stoffregen WC, Rogers DG, et al. West Nile virus infection in reindeer (Rangifer Tarandus). J Vet Diagn Invest. 2004;16(3):219–222.
   PubMed Web of Science ®Google Scholar
• Rimoldi G, Mete A, Adaska JM, et al. West Nile virus infection in sheep. Vet Pathol. 2017;54(1):155–158.
   PubMed Web of Science ®Google Scholar
• Heinz-Taheny KM, Andrews JJ, Kinsel MJ, et al. West Nile virus infection in free-ranging squirrels in illinois. J Vet Diagn Invest. 2004;16(3):186–190.
   PubMed Web of Science ®Google Scholar
• Venter M, Human S, Zaayman D, et al. Lineage 2 west nile virus as cause of fatal neurologic disease in horses, South Africa. Emerg Infect Dis. 2009;15(6):877–884.
   PubMed Web of Science ®Google Scholar
• Gomez A, Kramer LD, Dupuis AP 2nd, et al. Experimental infection of eastern gray squirrels (Sciurus carolinensis) with West Nile virus. Am J Trop Med Hyg. 2008;79(3):447–451.
   PubMed Web of Science ®Google Scholar
• Kiupel M, Simmons HA, Fitzgerald SD, et al. West Nile virus infection in eastern fox squirrels (Sciurus niger). Vet Pathol. 2003;40(6):703–707.
   PubMed Web of Science ®Google Scholar
• Porter RS, Leblond A, Lecollinet S, et al. Clinical diagnosis of West Nile Fever in Equids by classification and regression tree (CART) analysis and comparative study of clinical appearance in three European countries. Transbound Emerg Dis. 2011;58(3):197–205.
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Bildfell RJ, Gardner-Graff KK, et al. West Nile virus infection in two alpacas. J Am Vet Med Assoc. 2004;225(921–924):880.
   PubMedGoogle Scholar
• Dutton CJ, Quinnell M, Lindsay R, et al. Paraparesis in a polar bear (Ursus maritimus) associated with West Nile virus infection. J Zoo Wildl Med. 2009;40(3):568–571.
   PubMed Web of Science ®Google Scholar
• Cantile C, Di Guardo G, Eleni C, et al. Clinical and neuropathological features of West Nile virus equine encephalomyelitis in Italy. Equine Vet J. 2000;32(1):31–35.
   PubMed Web of Science ®Google Scholar
• Miller DL, Radi ZA, Baldwin C, et al. Fatal West Nile virus infection in a white-tailed deer (Odocoileus virginianus). J Wildl Dis. 2005;41(1):246–249.
   PubMed Web of Science ®Google Scholar
• Yaeger M, Yoon KJ, Schwartz K, et al. West Nile virus meningoencephalitis in a Suri alpaca and Suffolk ewe. J Vet Diagn Invest. 2004;16(1):64–66.
   PubMed Web of Science ®Google Scholar
• Cantile C, Del Piero F, Di Guardo G, et al. Pathologic and immunohistochemical findings in naturally occuring West Nile virus infection in horses. Vet Pathol. 2001;38(4):414–421.
   PubMed Web of Science ®Google Scholar
• Monath TP, Liu J, Kanesa-Thasan N, et al. A live, attenuated recombinant West Nile virus vaccine. Proc Natl Acad Sci U S A. 2006;103(17):6694–6699.
   PubMed Web of Science ®Google Scholar
• Biedenbender R, Bevilacqua J, Gregg AM, et al. Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults. J Infect Dis. 2011;203(1):75–84.
   PubMed Web of Science ®Google Scholar
• Dayan GH, Bevilacqua J, Coleman D, et al. Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age. Vaccine. 2012;30(47):6656–6664.
   PubMed Web of Science ®Google Scholar
• Durbin AP, Wright PF, Cox A, et al. The live attenuated chimeric vaccine rWN/DEN4Delta30 is well-tolerated and immunogenic in healthy flavivirus-naive adult volunteers. Vaccine. 2013;31(48):5772–5777.
   PubMed Web of Science ®Google Scholar
• Pierce KK, Whitehead SS, Kirkpatrick BD, et al. A live attenuated chimeric West Nile virus vaccine, rWN/DEN4Delta30, is well tolerated and immunogenic in Flavivirus-Naive older adult volunteers. J Infect Dis. 2017;215(1):52–55.
   PubMed Web of Science ®Google Scholar
• Martin JE, Pierson TC, Hubka S, et al. A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial. J Infect Dis. 2007;196(12):1732–1740.
   PubMed Web of Science ®Google Scholar
• Ledgerwood JE, Pierson TC, Hubka SA, et al. A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial. J Infect Dis. 2011;203(10):1396–1404.
   PubMed Web of Science ®Google Scholar
• Coller B, Pai V, Weeks-Levy C, et al. Recombinant subunit west nile virus vaccine for protection of human subjects. USA: Hawaii Biotech Inc; 2012.
   Google Scholar
• Barrett PN, Terpening SJ, Snow D, et al. Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases. Expert Rev Vaccines. 2017;16(9):883–894.
   PubMed Web of Science ®Google Scholar
• Woods CW, Sanchez AM, Swamy GK, et al. An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus vaccine, HydroVax-001, in healthy adults. Vaccine. 2019;37(30):4222–4230.
   PubMed Web of Science ®Google Scholar